central drugs standard control organization
Unapproved Fixed-Dose Drugs Pose Problem In India
Nearly 70 percent of anti-depressant FDCs bought in India between 2011 and 2012 were not approved by the Central Drugs Standard Control Organization.
Ranbaxy Fines: More Than Meets The Eye
Indian generics manufacturer Ranbaxy was recently slapped with fines by the U.S. FDA for the manufacturing and distribution of 'adulterated' drugs.




